Biomater. Sci., 2025, Accepted Manuscript
DOI: 10.1039/D5BM01349F, Paper
DOI: 10.1039/D5BM01349F, Paper
Open Access
  This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.Lucia Paolini, Miriam Romano, Valentina Mangolini, Selene Tassoni, Shuhan Jiang, Elena Laura Mazzoldi, Angelo Musicò, Andrea Zendrini, Anna Kashkanova, Vahid Sandoghdar, Anna Concetta Berardi, Silvia Clara Giliani, Paolo Bergese, Annalisa Radeghieri
Red blood cell-derived extracellular vesicles (RBC-EVs) are emerging as promising biomaterials for next-generation drug delivery, owing to their intrinsic biocompatibility, immune evasion properties, and minimal oncogenic risk. However, their broader...
The content of this RSS Feed (c) The Royal Society of Chemistry
Red blood cell-derived extracellular vesicles (RBC-EVs) are emerging as promising biomaterials for next-generation drug delivery, owing to their intrinsic biocompatibility, immune evasion properties, and minimal oncogenic risk. However, their broader...
The content of this RSS Feed (c) The Royal Society of Chemistry
.png)









English (US)